Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre,Parallel-group,Double-blind,Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Apomorphine sc Infusion in Parkinson's Disease Patients With Motor Complications Not Well Controlled on Medical Treatment

NCT02006121 is registered in ClinicalTrials.gov with Britannia Pharmaceuticals Ltd. as lead sponsor.

NCT NCT02006121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02006121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre,Parallel-group,Double-blind,Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Apomorphine sc Infusion in Parkinson's Disease Patients With Motor Complications Not Well Controlled on Medical Treatment
Lead sponsor
Britannia Pharmaceuticals Ltd.
Phase
Phase 3
Overall status
Completed
Start date
March 3, 2014
Completion date
June 8, 2017
Enrollment
107 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease